Manuscripts must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the Declaration of Helsinki(as revised in Brazil in October 2013). This approval must be declared in the Methods section of the article with the inclusion of the name of the committee. In addition, patient anonymity must be preserved at all times. The journal will not publish pictures that identify patients unless the authors submit evidence of written consent from the patient or a legal guardian. The JPR Patient Consent form can be found here.
Reports of animal experiments must state that the principles of the care and use of animals for scientific purposes were followed, as well as any specific national or local institutional laws where applicable.
Jurnal Plastik Rekonstruksi® requires all articles reporting results of clinical trials to be registered in a public trials registry that is in conformity with the International Committee of Medical Journal Editors (ICMJE). All clinical trials, regardless of when they were completed, and secondary analyses of original clinical trials must be registered before submission of a manuscript based on the trial. Phase I trials designed to study pharmacokinetics or major toxicity are exempt.
Manuscripts reporting on clinical trials (as defined above) should indicate that the trials are registered and include the registry information on a separate page, immediately following the authors’ financial disclosure information. Required registry information must include the trial registry name, registration identification number, and the URL for the registry.
Reporting of randomized controlled trials should follow the guidelines of The CONSORT Statement (Consolidated Standards of Reporting Trials).
Clinical trials should be clearly identified as such in the title and abstract. A clinical trial is any study that prospectively assigns humans into groups to study the relationship between an intervention and a clinical outcome. Clinical trials should adhere to the guidelines outlined in the CONSORT Statement and all manuscripts must include a flow chart showing the progress of patients through the trial.
Clinical trial registration
The journal requires that the clinical trials submitted for its consideration are registered in a publicly accessible database. The authors should include the name of the trial register and their clinical trial registration number in the acknowledgments section of their manuscript. If you wish the editor/s to consider an unregistered trial, please explain briefly why the trial has not been registered.
All systematic reviews of clinical trials must adhere to the guidelines outlined in the MOOSE report by the CONSORT Group. The authors should include a section describing the methods used for locating, selecting, extracting, and synthesizing data. The authors are encouraged to use subheadings in the main text of the manuscript. The structured abstract should have the following sections: Background, Objectives, Data sources, Review methods, Results, and Conclusions.
All meta-analyses of randomized trials must adhere to the guidelines outlined in the PRISMA Statement which is designed to improve manuscript quality. Meta-analyses authors should review their papers against these guidelines before submission and can find the recommended PRISMA flow chart here and a sample checklist here.